A randomised, prospective study of the effects of 3% diquafosol on ocular surface following cataract surgery

Abstract There is still no established therapeutic solution for postoperative Dry Eye Syndrome (DES) after cataract surgery, in spite of progress in surgical techniques. Diquafosol tetrasodium (DQS), a recently developed ophthalmic solution, has been reported to be effective in DES, but no study eva...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sangyoon Kim, Jonghoon Shin, Ji Eun Lee
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9557fd5aa3fe47c69d9dfc56eea9da3a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9557fd5aa3fe47c69d9dfc56eea9da3a
record_format dspace
spelling oai:doaj.org-article:9557fd5aa3fe47c69d9dfc56eea9da3a2021-12-02T13:41:23ZA randomised, prospective study of the effects of 3% diquafosol on ocular surface following cataract surgery10.1038/s41598-021-88589-72045-2322https://doaj.org/article/9557fd5aa3fe47c69d9dfc56eea9da3a2021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-88589-7https://doaj.org/toc/2045-2322Abstract There is still no established therapeutic solution for postoperative Dry Eye Syndrome (DES) after cataract surgery, in spite of progress in surgical techniques. Diquafosol tetrasodium (DQS), a recently developed ophthalmic solution, has been reported to be effective in DES, but no study evaluated post-cataract surgery lipid layer thickness (LLT) changes in healthy patients who used DQS postoperatively. We randomly divided participants into two groups; the DQS group was treated six times daily with DQS after cataract surgery, and the sodium hyaluronate (HA) group was treated with HA in the same way. Throughout study period, the DQS group showed significantly higher tear break up time (TBUT) and LLT than HA group. In multivariate analysis, better preoperative TBUT, Schirmer’s I test score, ocular surface disease index (OSDI) score, and LLT were significantly associated with improved postoperative outcomes in each parameter. Also, the postoperative use of DQS served as an independent parameter of better TBUT, OSDI score, and LLT in postoperative 15 weeks. Treatment with 3% DQS following cataract surgery showed more improvement in TBUT and LLT, compared with 0.1% HA. Improving TBUT and LLT preoperatively and using 3% DQS postoperatively, could be a reliable choice for managing DES after cataract surgery. Trial Registration: ISRCTN registry with ISRCTN 18755487.Sangyoon KimJonghoon ShinJi Eun LeeNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Sangyoon Kim
Jonghoon Shin
Ji Eun Lee
A randomised, prospective study of the effects of 3% diquafosol on ocular surface following cataract surgery
description Abstract There is still no established therapeutic solution for postoperative Dry Eye Syndrome (DES) after cataract surgery, in spite of progress in surgical techniques. Diquafosol tetrasodium (DQS), a recently developed ophthalmic solution, has been reported to be effective in DES, but no study evaluated post-cataract surgery lipid layer thickness (LLT) changes in healthy patients who used DQS postoperatively. We randomly divided participants into two groups; the DQS group was treated six times daily with DQS after cataract surgery, and the sodium hyaluronate (HA) group was treated with HA in the same way. Throughout study period, the DQS group showed significantly higher tear break up time (TBUT) and LLT than HA group. In multivariate analysis, better preoperative TBUT, Schirmer’s I test score, ocular surface disease index (OSDI) score, and LLT were significantly associated with improved postoperative outcomes in each parameter. Also, the postoperative use of DQS served as an independent parameter of better TBUT, OSDI score, and LLT in postoperative 15 weeks. Treatment with 3% DQS following cataract surgery showed more improvement in TBUT and LLT, compared with 0.1% HA. Improving TBUT and LLT preoperatively and using 3% DQS postoperatively, could be a reliable choice for managing DES after cataract surgery. Trial Registration: ISRCTN registry with ISRCTN 18755487.
format article
author Sangyoon Kim
Jonghoon Shin
Ji Eun Lee
author_facet Sangyoon Kim
Jonghoon Shin
Ji Eun Lee
author_sort Sangyoon Kim
title A randomised, prospective study of the effects of 3% diquafosol on ocular surface following cataract surgery
title_short A randomised, prospective study of the effects of 3% diquafosol on ocular surface following cataract surgery
title_full A randomised, prospective study of the effects of 3% diquafosol on ocular surface following cataract surgery
title_fullStr A randomised, prospective study of the effects of 3% diquafosol on ocular surface following cataract surgery
title_full_unstemmed A randomised, prospective study of the effects of 3% diquafosol on ocular surface following cataract surgery
title_sort randomised, prospective study of the effects of 3% diquafosol on ocular surface following cataract surgery
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/9557fd5aa3fe47c69d9dfc56eea9da3a
work_keys_str_mv AT sangyoonkim arandomisedprospectivestudyoftheeffectsof3diquafosolonocularsurfacefollowingcataractsurgery
AT jonghoonshin arandomisedprospectivestudyoftheeffectsof3diquafosolonocularsurfacefollowingcataractsurgery
AT jieunlee arandomisedprospectivestudyoftheeffectsof3diquafosolonocularsurfacefollowingcataractsurgery
AT sangyoonkim randomisedprospectivestudyoftheeffectsof3diquafosolonocularsurfacefollowingcataractsurgery
AT jonghoonshin randomisedprospectivestudyoftheeffectsof3diquafosolonocularsurfacefollowingcataractsurgery
AT jieunlee randomisedprospectivestudyoftheeffectsof3diquafosolonocularsurfacefollowingcataractsurgery
_version_ 1718392568840978432